SCHEMBL22489529

SCHEMBL22489529

CS(=O)(=O)Nc1ccc(CC(=O)N2CCN(c3ccc(Cl)nn3)CC2)cc1

nearest known ligand 0.68

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PANK3 Q9H999 18/20 0.68
GRIN1 Q05586 1/20 0.51
GRIN2B Q13224 1/20 0.51
TRPV1 Q8NER1 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22489667 0.91 PANK3 (0.67) PANK3TRPV1
SCHEMBL24507689 0.89 PANK3 (0.70) PANK3TRPV1
SCHEMBL22489656 0.87 PANK3 (0.73) PANK3TRPV1
SCHEMBL24507691 0.87 PANK3 (0.66) PANK3TRPV1
SCHEMBL22489680 0.85 PANK3 (0.63) PANK3TRPV1
SCHEMBL24507692 0.85 PANK3 (0.70) PANK3TRPV1
SCHEMBL22469964 0.85 PANK3 (0.71) PANK3TRPV1
SCHEMBL22489606 0.85 PANK3 (0.68) PANK3
SCHEMBL22489377 0.85 PANK3 (0.53) PANK3GRIN1GRIN2B
SCHEMBL22469871 0.84 PANK3 (0.69) PANK3TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185796-A1 SMALL MOLECULE MODULATORS OF PANK ST. JUDE CHILDREN'S RESEARCH HOSPITAL 2022-06-16 US disclosed
WO-2020198526-A2 SMALL MOLECULE MODULATORS OF PANK ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185796-A1 SMALL MOLECULE MODULATORS OF PANK PANK2, PANK1, PANK3 PANK3 3/4885GRIN1 1049/4885GRIN2B 937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.